Costs and Effectiveness of Influenza Vaccination: a Systematic Review

Overview

Journal Ann Ist Super Sanita

Specialty Public Health

Date 2018 Apr 5

PMID 29616674

Citations 25

Authors

Lucia Sara DAngiolella

Alessandra Lafranconi

Paolo Angelo Cortesi

Silvia Rota

Giancarlo Cesana

Lorenzo Giovanni Mantovani

Affiliations

Soon will be listed here.

Abstract

Background: Seasonal influenza can cause a significant public health burden. Vaccination is proposed as the most effective measure to prevent influenza and related undesired outcomes.

Objective: To estimate the efficiency of influenza vaccination.

Methods: A literature review of economic evaluations of influenza vaccinations, published over the last 5 years, was performed using MEDLINE (through PubMed), Web of Science and Scopus.

Results: 935 papers were identified and 30 were selected, including studies performed in different population subgroups: general population, children, adults, elderly, pregnant women and high risk patients. Twenty-one studies were performed in Europe and in US. The majority of the studies were carried out on elderly patients and children. All except one were cost-effectiveness analyses and reported influenza vaccination as a cost-saving or cost-effective intervention.

Conclusions: Vaccination strategies are economically favourable in a range of countries and sub-groups of patients.

Citing Articles

A Pharmacoeconomic Study of Post-Exposure Prophylaxis Strategies for Influenza Virus Infections in Japan.

Nakagawa N, Ono R, Odanaka K, Ohara H, Kisara S, Ito K Adv Ther. 2024; 42(2):772-787.

PMID: 39636568 DOI: 10.1007/s12325-024-02988-6.

Comparison of the influenza vaccination coverage among high-risk people between the online registration system and walk-in service system in Bangkok, Thailand.

Sairuk R, Nishino K, Inthaphatha S, Hamajima N, Yamamoto E Nagoya J Med Sci. 2024; 86(2):252-261.

PMID: 38962419 PMC: 11219236. DOI: 10.18999/nagjms.86.2.252.

Costs and cost-effectiveness of influenza illness and vaccination in low- and middle-income countries: A systematic review from 2012 to 2022.

Gharpure R, Chard A, Cabrera Escobar M, Zhou W, Valleau M, Yau T PLoS Med. 2024; 21(1):e1004333.

PMID: 38181066 PMC: 10802964. DOI: 10.1371/journal.pmed.1004333.

Assessing the Intense Influenza A(H1N1)pdm09 Epidemic and Vaccine Effectiveness in the Post-COVID Season in the Russian Federation.

Sominina A, Danilenko D, Komissarov A, Pisareva M, Fadeev A, Konovalova N Viruses. 2023; 15(8).

PMID: 37632122 PMC: 10458445. DOI: 10.3390/v15081780.

Sustained Increase in Very Low Influenza Vaccination Coverage in Residents and Healthcare Workers of Long-Term Care Facilities in Austria after Educational Interventions.

Boyer J, Konig E, Friedl H, Pux C, Uhlmann M, Schippinger W Vaccines (Basel). 2023; 11(6).

PMID: 37376455 PMC: 10302292. DOI: 10.3390/vaccines11061066.